BLLN

BillionToOne, Inc.

NasdaqHealthcareServices-Medical Laboratories

Insider activity for last month from 09/19 to 10/19.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$7.43M32 sells
Net open-market−$7.43MBuying minus selling
Active insiders4Distinct reporting owners

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Oct 16, 2026

Open-market transaction mix · 32 transactions in the selected period
0 buys0%·100%32 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Sep 2026050$0$2.06M-$2.06M
Oct 20260270$0$5.37M-$5.37M

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (4)
Sep 2026: 3 insidersOct 2026: 4 insiders
Sep 2026Oct 2026
4distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
1 insiders
  • AO
    Atay OguzhanCHAIR · 0 buys · 14 sells · 0 awards (A)
    -$2.9Mlast 10/16/2026

BLLN transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
CompanyInsiderActivityDisclosed valueFiled (ET)
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRM · exercise10b5-1 detectedDerivative securitySEC filing ↗-$14.4kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRM · exercise10b5-1 detectedDerivative securitySEC filing ↗-$8.91kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$261kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$13.6kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$99.7kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$128kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$185kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$88.5kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRM · exercise10b5-1 detectedSEC filing ↗$14.4kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$9.90kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$303kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRM · exercise10b5-1 detectedSEC filing ↗$8.91kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRM · exercise10b5-1 detectedDerivative securitySEC filing ↗-$46.6kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$260kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$146kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$366kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$633kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$237kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRS · sale10b5-1 detectedSEC filing ↗-$179kView disclosure →
BLLNBillionToOne, Inc.
Atay OguzhanCHAIRM · exercise10b5-1 detectedSEC filing ↗$46.6kView disclosure →
Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale$1.00M
10b5-1 detected46
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
48transactionstxns
  • S · Open-market sells · dominant32 · 67%
  • M · Option exercise16 · 33%

Activity by reported role

A joint filing can contribute to multiple roles
CHAIR24
CTO18
SLO4
SR2

Reported Holdings After

Separated by insider, security, and ownership type

Atay OguzhanClass A Common Stock · Direct
16.7k0Sep 28, 2026Oct 15, 2026
0Oct 15, 2026
Tsao DavidClass A Common Stock · Direct
21.0k1.0kSep 24, 2026Oct 05, 2026
1,000Oct 05, 2026
Atay OguzhanStock Option (right to buy) · Direct
493.6k468.6kSep 28, 2026Oct 15, 2026
468,629Oct 15, 2026
Tsao DavidStock Option (right to buy) · Direct
556.7k536.7kSep 24, 2026Oct 05, 2026
536,667Oct 05, 2026
Atay OguzhanClass A Common Stock · Indirect · By spouse
154.5k149.2kSep 28, 2026Oct 14, 2026
149,168Oct 14, 2026
Lynch Thomas P.Class A Common Stock · Direct
8.7k8.7kOct 08, 2026Oct 08, 2026
8,700Oct 08, 2026
Lynch Thomas P.Stock Option (right to buy) · Direct
41.0k41.0kOct 08, 2026Oct 08, 2026
40,974Oct 08, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
2 active days
Sep 19 → Oct 19
LessMore

BillionToOne, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at BillionToOne, Inc.?

Atay Oguzhan, Lynch Thomas P., ten Bosch John Roderick, Tsao David.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Atay Oguzhan reported a sale on Oct 15, 2026 valued at $13.6k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $7,439,394.13. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.